Location History:
- Brussels, BE (2002 - 2008)
- Chastre, BE (2015)
Company Filing History:
3 out of 525 
2 out of 832,880 Years Active: 2002-2015
Title: Nathalie Demotte: Innovator in T Lymphocyte Modulation
Introduction
Nathalie Demotte is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of immunology, particularly in the modulation of T lymphocyte activity. With a total of 5 patents, her work has the potential to impact cancer research and treatment.
Latest Patents
One of her latest patents is a method for modulating the activity of T lymphocytes. This invention relates to methods and compositions that modulate T lymphocyte activity by altering the distance between two key receptors, TCR and CD8, on T lymphocyte surfaces. By using modulators that change this distance, the activity of T lymphocytes can be effectively modulated. Another notable patent involves the isolation of cytotoxic T lymphocyte (CTL) clones that are specific for proteins of the MAGE family. This invention details a novel procedure for isolating CTL clones through successive stimulation and testing of lymphocytes with antigen-presenting cells.
Career Highlights
Nathalie has worked with the Ludwig Institute for Cancer Research Limited, where she has furthered her research in immunology. Her innovative approaches have garnered attention in the scientific community, contributing to advancements in cancer therapies.
Collaborations
Throughout her career, Nathalie has collaborated with notable colleagues, including Rosalie Luiten and Marie-Therese Duffour. These partnerships have enriched her research and expanded the impact of her inventions.
Conclusion
Nathalie Demotte's work in T lymphocyte modulation showcases her dedication to advancing cancer research. Her innovative patents and collaborations highlight her significant role in the field of immunology.